| Code: MTA12855 | Publication Date: Jun 2026 |
India pleurisy market is a specialized and growing segment of the country's respiratory and pharmaceutical sector, driving enhanced patient care and treatment outcomes. Key players in the market are AstraZeneca, GlaxoSmithKline, Pfizer, and Sun Pharmaceutical Industries.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full India pleurisy market.
According to 6Wresearch, the India pleurisy market is witnessing steady growth due to rising respiratory disorders, increasing hospitalizations, and growing awareness about early diagnosis and treatment. The demand for pleurisy drugs and therapies is increasing in hospitals and clinics, supported by government health initiatives and expansion of healthcare infrastructure.
The competitive landscape of India pleurisy market is characterized by the presence of global pharmaceutical giants and well-established Indian manufacturers. These companies provide a wide variety of treatments, including antibiotics, anti-inflammatory therapies, and supportive care solutions.
Leading Players Operating in the India Pleurisy Market:
| Company Name | AstraZeneca |
|---|---|
| Established Year | 1999 |
| Headquarters | Cambridge, United Kingdom |
| Official Website | Click Here |
A global leader in respiratory biologics, AstraZeneca provides advanced targeted therapies that effectively manage underlying inflammatory pathways in pleural conditions.
| Company Name | GlaxoSmithKline |
|---|---|
| Established Year | 2000 |
| Headquarters | Brentford, United Kingdom |
| Official Website | Click Here |
Renowned for its expansive portfolio of inhalers and systemic respiratory medications, the company focuses on long-term management of pleural inflammation and comorbid asthma.
| Company Name | Pfizer |
|---|---|
| Established Year | 1849 |
| Headquarters | New York, USA |
| Official Website | Click Here |
A pioneer in infectious disease and anti-inflammatory treatments, Pfizer delivers robust clinical solutions for managing pleurisy caused by bacterial and inflammatory triggers.
| Company Name | Sun Pharmaceutical Industries |
|---|---|
| Established Year | 1983 |
| Headquarters | Mumbai, India |
| Official Website | Click Here |
Offers a vast array of specialized formulations that assist in systemic treatment, supporting the rapid response requirements of the Indian hospital network.
| Company Name | Becton, Dickinson and Company |
|---|---|
| Established Year | 1897 |
| Headquarters | Franklin Lakes, USA |
| Official Website | Click Here |
A leader in medical technology, the company provides critical drainage catheters and diagnostic procedural kits essential for the clinical management of pleural effusion.
| Company Name | Siemens Healthineers |
|---|---|
| Established Year | 1847 |
| Headquarters | Erlangen, Germany |
| Official Website | Click Here |
Integrates cutting-edge medical imaging systems that allow for high-precision diagnostic visualization of pleural surfaces and fluid distribution.
| Company Name | Dr. Reddy's Laboratories |
|---|---|
| Established Year | 1984 |
| Headquarters | Hyderabad, India |
| Official Website | Click Here |
Combines strong research and development in generics with innovative respiratory drug delivery systems that serve the domestic Indian patient population.
| Company Name | Olympus Corporation |
|---|---|
| Established Year | 1919 |
| Headquarters | Tokyo, Japan |
| Official Website | Click Here |
A world leader in optical and diagnostic imaging, providing essential bronchoscopy equipment used for the diagnosis and treatment of pleural pathologies.
| Company Name | Merck & Co. |
|---|---|
| Established Year | 1891 |
| Headquarters | Rahway, USA |
| Official Website | Click Here |
Focuses on the development of novel therapeutic candidates that target specific respiratory inflammatory triggers, advancing the science of pleural health.
| Company Name | Bayer AG |
| Established Year | 1863 |
| Headquarters | Leverkusen, Germany |
| Official Website | Click Here |
A global giant in life sciences, Bayer contributes to the pleurisy market by developing specialized anti-inflammatory agents and advanced imaging contrast media that aid in precise pleural diagnostic procedures.